Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 ·
Decision snapshot: CACI stock price vs HCA: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at HCA's multiple
Needs HCA P/E.
Implied fair value · at CACI's multiple
Needs CACI P/E.
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple premium
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: CACI FY 2026 (ended Jun 30, 2026) · HCA FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 74% equity / 26% debt · EV / Revenue 1.94x · EV / EBITDA 17.07x
Capital structure 65% equity / 35% debt · EV / Revenue 1.83x · EV / EBITDA 8.19x
HCA carries the larger enterprise value at $137.98B against $18.54B; HCA trades on the lower EV / Revenue multiple (1.83x vs 1.94x); HCA on the lower EV / EBITDA (8.19x vs 17.07x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
CACI INTERNATIONAL INC · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
HCA Healthcare, Inc. · implied price per share
Bear
$171.11
Base
$241.68
Bull
$336.89
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
1.11x
-8.16x
Net debt / EBITDA
Leverage against operating earnings
4.38x
2.86x
Cash and equivalents
Liquid reserves on the balance sheet
$191.76M
$1.04B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Science Applications International Corp
CACI vs SAIC
KBR, INC.
CACI vs KBR
Booz Allen Hamilton Holding Corp
CACI vs BAH
Leidos Holdings, Inc.
CACI vs LDOS
JACOBS SOLUTIONS INC.
CACI vs J
LABCORP HOLDINGS INC.
CACI vs LH
WEST PHARMACEUTICAL SERVICES INC
CACI vs WST
BAXTER INTERNATIONAL INC
CACI vs BAX
MCKESSON CORP
CACI vs MCK
Cigna Group
CACI vs CI
UNITEDHEALTH GROUP INC
CACI vs UNH
$4.95B
$49.17B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
